首页> 美国卫生研究院文献>Advances in Pharmacological Sciences >Gnidia glauca- and Plumbago zeylanica-Mediated Synthesis of Novel Copper Nanoparticles as Promising Antidiabetic Agents
【2h】

Gnidia glauca- and Plumbago zeylanica-Mediated Synthesis of Novel Copper Nanoparticles as Promising Antidiabetic Agents

机译:Gnidia glauca-和Plumbago zeylanica介导的新型铜纳米颗粒合成作为有望的抗糖尿病药

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Rapid, eco-friendly, and cost-effective one-pot synthesis of copper nanoparticles is reported here using medicinal plants like Gnidia glauca and Plumbago zeylanica. Aqueous extracts of flower, leaf, and stem of G. glauca and leaves of P. zeylanica were prepared which could effectively reduce Cu2+ ions to CuNPs within 5 h at 100°C which were further characterized using UV-visible spectroscopy, field emission scanning electron microscopy, high-resolution transmission electron microscopy, energy dispersive spectroscopy, dynamic light scattering, X-ray diffraction, and Fourier-transform infrared spectroscopy. Further, the CuNPs were checked for antidiabetic activity using porcine pancreatic α-amylase and α-glucosidase inhibition followed by evaluation of mechanism using circular dichroism spectroscopy. CuNPs were found to be predominantly spherical in nature with a diameter ranging from 1 to 5 nm. The phenolics and flavonoids in the extracts might play a critical role in the synthesis and stabilization process. Significant change in the peak at ∼1095 cm−1 corresponding to C-O-C bond in ether was observed. CuNPs could inhibit porcine pancreatic α-amylase up to 30% to 50%, while they exhibited a more significant inhibition of α-glucosidase from 70% to 88%. The mechanism of enzyme inhibition was attributed due to the conformational change owing to drastic alteration of secondary structure by CuNPs. This is the first study of its kind that provides a strong scientific rationale that phytogenic CuNPs synthesized using G. glauca and P. zeylanica can be considered to develop candidate antidiabetic nanomedicine.
机译:据报道,使用药用植物如Gnidia glauca和Plumbago zeylanica可以快速,环保且经济高效地一锅法合成铜纳米颗粒。制备了G. glauca花,叶和茎的水提物和P. zeylanica的水提物,可以在100°C下5 h内有效地将Cu 2 + 离子还原为CuNPs,并进一步表征。紫外可见光谱,场发射扫描电子显微镜,高分辨率透射电子显微镜,能量色散光谱,动态光散射,X射线衍射和傅里叶变换红外光谱。此外,使用猪胰α-淀粉酶和α-葡萄糖苷酶抑制检查CuNPs的抗糖尿病活性,然后使用圆二色光谱法评估其机制。发现CuNPs本质上主要是球形的,直径范围为1至5nm。提取物中的酚类和类黄酮可能在合成和稳定过程中起关键作用。观察到〜1095 cm -1 处对应于醚中C-O-C键的峰发生了显着变化。 CuNPs最多可抑制猪胰腺α-淀粉酶达30%至50%,而它们对α-葡萄糖苷酶的抑制作用则更为显着,从70%至88%。酶抑制的机制归因于由于CuNP引起的二级结构的急剧改变而引起的构象变化。这是同类研究中的第一个,该研究提供了强有力的科学依据,认为可以认为使用青冈G. glauca和P. zeylanica合成的植物性CuNPs可以开发候选的抗糖尿病纳米药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号